不良研究所

Discover ioCells

Programmed identity
in every cell

View product catalogue
Human iPSC-derived cells powered by opti-ox, consistency and scalability are built-in.

Mature, functional human
iPSC-derived cells within days,
powered by opti-ox

The future of human health will be defined by technologies that accelerate the world's access to more effective medicines.

Human cells are a cornerstone of fundamental disease research, drug discovery, and clinical translation. Yet, despite decades of research into iPSCs, emerging cures for some of the world鈥檚 most pervasive diseases have been bottlenecked by a lack of access to standardised, easy to use and readily accessible human cells.

We built ioCells to solve this challenge.

Developed on our platform, and powered by opti-ox technology, ioCells are human cells deterministically programmed from iPSCs consistently, at scale. With ioCells, scientists no longer need to battle with variance, unreliability, physiological irrelevance and long experimental timelines. Instead, scientists can finally focus on the next great advances in human health.

ioCells are for research use only.

Browse ioCells portfolio

View product catalogue
ioSkeletal Myocytes_for partners module

ioWild Type Cells

ioWild Type Cells are defined, easy-to-use, functional iPSC-derived human cells from a healthy donor background that are ready for fundamental research and drug discovery experimentation within days.

Explore now
Discover ioCells portfolio ICC ioDisease model cells

ioDisease Model Cells

ioDisease Model Cells are ioWild Type Cells engineered to contain disease-relevant mutations. ioDisease Model Cells and ioWild Type Cells form an isogenic pair allowing scientists to make true comparisons.

Explore now
bb-CRISPR-ready-card

CRISPR-Ready ioCells

CRISPR-Ready ioCells are human iPSC-derived cells constitutively expressing Cas9 nuclease for rapid gene knockout generation. 

Explore now
bb-iotracker-cards

ioTracker Cells

ioTracker Cells are human iPSC-derived cells constitutively expressing a fluorescent protein for easy visualisation, tracking, and isolation of human cells in live-cell imaging assays.

Explore now

Benchtop benefits

consistent_0

Consistent

Our platform ensures consistency between every batch of cells, overcoming the challenge of data reproducibility.

cost_0

Cost-effective

ioCells generate quality data at industry leading seeding densities. You can do more with every vial as every well saves you money.

defined_0

Defined

Every ioCell has its identity characterised by ICC, RT-qPCR and RNA-Seq at minimum.

easy_0

Easy-to-use

ioCells are delivered cryopreserved and require a simple protocol using an open-source medium to get started.

quick_0

Quick

Deterministically programmed cells mature rapidly, meaning cells are ready for experimentation and data gathering within days post-revival.

scalable_0

Scalable

With opti-ox technology we can make billions of consistently programmed cells, surpassing the demands of industrial workflows.

What Scientists Say About ioCells

An image of Dr Marijn Vlaming

Dr Marijn Vlaming

Head of Biology - Beerse & Leiden | Charles River

"Using more relevant cell models such as ioCells from 不良研究所 helps us to test safety and toxicity in vitro, in parallel with efficacy, and as such we will be able to identify the safe or unsafe drug candidates very early in the drug discovery process"

An image of Dr Mariangela Iovino

Dr Mariangela Iovino

Senior Group Leader | Biology Discovery | Charles River

鈥淭hese cells were really easy-to-use and ready to be plated in the assay format"

An image of Rodney A. Bowling Jr, PhD

Rodney A. Bowling Jr, PhD

Co-Founder & Chief Scientific Officer | Everlum Bio

"I found the customer service at 不良研究所 to be a premium, I found it to be wonderful鈥�

Our deterministic cell programming technology

 

opti-ox-cell_7fps_v03_00033

Every ioCell is powered by opti-ox.


Using opti-ox, populations of stem cells are precisely and consistently programmed into a chosen cell identity. Each vial of ioCells contains a defined and highly characterised population of iPSC-derived human cells that are ready for quality data production in a matter of days. Their high lot-to-lot consistency provides a reliable cell model that enables scientists to conduct repeatable and scalable experiments in drug discovery and disease research. 

Compare opti-ox to other iPSC differentiation methods

Product resources

High Content Analysis of 2D and 3D cellular models for target and phenotypic drug discovery Poster
High Content Analysis of 2D and 3D cellular models for target and phenotypic drug discovery

Lachize, et al

Courtesy of Charles River Laboratories

2020

View poster
Genotype and phenotype validation of an isogenic human iPSC-derived neuronal model of Huntington鈥檚 Disease Poster
Genotype and phenotype validation of an isogenic human iPSC-derived neuronal model of Huntington鈥檚 Disease

Oosterveen, et al

不良研究所

2022

View poster
Rapid and consistent generation of functional microglia from reprogrammed hiPSCs to study neurodegeneration and neuroinflammation Poster
Rapid and consistent generation of functional microglia from reprogrammed hiPSCs to study neurodegeneration and neuroinflammation

Raman, et al

不良研究所

2022

View poster
Stimulating 3D Skeletal Muscle Microtissues in a Novel Perfusable Microphysiological System with Integrated Electrodes Poster
Stimulating 3D Skeletal Muscle Microtissues in a Novel Perfusable Microphysiological System with Integrated Electrodes

Dr Mitchell Han

Bi/ond

2023

View poster
Rapid and consistent generation of functional motor neurons from reprogrammed human iPSCs using opti-ox technology Poster
Rapid and consistent generation of functional motor neurons from reprogrammed human iPSCs using opti-ox technology

Vaquero, et al

不良研究所

2023

View poster
Generation and characterisation of a panel of human iPSC-derived neurons and microglia carrying early and late onset relevant mutations for Alzheimer鈥檚 disease Poster
Generation and characterisation of a panel of human iPSC-derived neurons and microglia carrying early and late onset relevant mutations for Alzheimer鈥檚 disease

Smith, et al. 

不良研究所

2024

View poster
Generation and functional characterisation of motor neurons derived through transcription factor mediated programming of human pluripotent stem cells Poster
Generation and functional characterisation of motor neurons derived through transcription factor mediated programming of human pluripotent stem cells

Foulser, et al 

不良研究所

2024

View poster
CRISPR knockout screening for drug target identification and validation using CRISPR-Ready ioMicroglia Poster
CRISPR knockout screening for drug target identification and validation using CRISPR-Ready ioMicroglia

Schmidt, et al

不良研究所

2024

Download poster
Generation of human iPSC-derived Duchenne muscular dystrophy skeletal myocytes suitable for 3D functional studies and investigating methods for dystrophin restoration Poster
Generation of human iPSC-derived Duchenne muscular dystrophy skeletal myocytes suitable for 3D functional studies and investigating methods for dystrophin restoration

Bernard, et al

不良研究所

2024

View poster
Advancing drug discovery: leveraging CRISPR-Ready ioMicroglia for functional genomics studies Poster
Advancing drug discovery: leveraging CRISPR-Ready ioMicroglia for functional genomics studies

Schmidt et al.

不良研究所

2024

View poster
Alzheimer鈥檚 disease models in iPSC-derived glutamatergic neurons show increased secretion of pathogenic amyloid beta peptides Poster
Alzheimer鈥檚 disease models in iPSC-derived glutamatergic neurons show increased secretion of pathogenic amyloid beta peptides

Veteleanu et al.

不良研究所

2025

View poster
Amyloid-beta induces toxicity and cell death in human iPSC-derived neurons: alzheimer disease in vitro model Poster
Amyloid-beta induces toxicity and cell death in human iPSC-derived neurons: alzheimer disease in vitro model

Bsibsi et al.

Courtesy of Charles River Laboratories

2024

View poster
An in vitro toolkit to study the cell-specific roles of glutamatergic neurons and glia in Alzheimer鈥檚 disease Poster
An in vitro toolkit to study the cell-specific roles of glutamatergic neurons and glia in Alzheimer鈥檚 disease

Oosterveen et al.

不良研究所

2025

View poster
An iPSC-derived neuroinflammation/neurotoxicity in vitro model of neurons and glial cells Poster
An iPSC-derived neuroinflammation/neurotoxicity in vitro model of neurons and glial cells

Bsibsi et al.

Courtesy of Charles River Laboratories

2024

View poster
Characterization of a human iPSC derived Huntington鈥檚 disease cell line suitable for disease modelling and drug screening Poster
Characterization of a human iPSC derived Huntington鈥檚 disease cell line suitable for disease modelling and drug screening

Iovino et al.

Courtesy of Charles River Laboratories

2023

View poster
Driving experimental reproducibility and lot-to-lot biological consistency in human iPSC-derived cells enabled by opti-ox technology Poster
Driving experimental reproducibility and lot-to-lot biological consistency in human iPSC-derived cells enabled by opti-ox technology

Newman et al.

不良研究所

2024

View poster
Rapid and consistent generation of human iPSC-derived oligodendrocyte-like cells using opti-ox technology Poster
Rapid and consistent generation of human iPSC-derived oligodendrocyte-like cells using opti-ox technology

Herrera-Vaquero et al.

不良研究所

2024

View poster
Establishment and validation of an in vitro co-culture model to study myelination using human iPSC-derived glutamatergic neurons and oligodendrocytes Poster
Establishment and validation of an in vitro co-culture model to study myelination using human iPSC-derived glutamatergic neurons and oligodendrocytes

Bsibsi et al.

Courtesy of Charles River Laboratories

2024

View poster
Generation and functional characterisation of motor neurons derived through transcription factor mediated programming of human pluripotent stem cells Poster
Generation and functional characterisation of motor neurons derived through transcription factor mediated programming of human pluripotent stem cells

Brown et al.

不良研究所

2024

View poster
Harnessing CRISPR-Ready ioCells as functional genomics tools for drug target identification and validation Poster
Harnessing CRISPR-Ready ioCells as functional genomics tools for drug target identification and validation

Grabner et al.

不良研究所

2025

View poster
Modelling neurodegeneration using a human genetically matched system: a next generation approach to study frontotemporal dementia and amyotrophic lateral sclerosis Poster
Modelling neurodegeneration using a human genetically matched system: a next generation approach to study frontotemporal dementia and amyotrophic lateral sclerosis

Smith et al.

不良研究所

2024

View poster
Optimised and scalable programming of human iPSCs to generate nociceptor sensory neurons for the study of pain mechanisms and neuropathies Poster
Optimised and scalable programming of human iPSCs to generate nociceptor sensory neurons for the study of pain mechanisms and neuropathies

Oosterveen et al.

不良研究所

2024

View poster
Physiologically relevant media unmasks severe mitochondrial dysfunction in a precision reprogrammed iPSC-derived model of Huntington's disease Poster
Physiologically relevant media unmasks severe mitochondrial dysfunction in a precision reprogrammed iPSC-derived model of Huntington's disease

Monteith et al.

不良研究所

2024

View poster
Scalable and well defined human glutamatergic and gabaergic co-culture platform for studying excitatory-inhibitory neuron imbalances and the discovery of drugs to treat associated diseases Poster
Scalable and well defined human glutamatergic and gabaergic co-culture platform for studying excitatory-inhibitory neuron imbalances and the discovery of drugs to treat associated diseases

Krainz et al.

不良研究所

2024

View poster
Identification of neuronal subtype-specific splice variants in iPSC-derived cell models of ALS and FTD Poster
Identification of neuronal subtype-specific splice variants in iPSC-derived cell models of ALS and FTD

Veteleanu et al.

不良研究所

2025

Download poster
iPSC-derived Alzheimer's disease models show increased secretion of pathogenic amyloid beta peptides in glutamatergic neurons and responses to amyloid beta 42 in microglia Poster
iPSC-derived Alzheimer's disease models show increased secretion of pathogenic amyloid beta peptides in glutamatergic neurons and responses to amyloid beta 42 in microglia

Veteleanu et al.

不良研究所

2025

Download poster
A versatile toolbox of human iPSC-derived microglia for disease modelling and multicellular in vitro models for neurodegeneration drug discovery Poster
A versatile toolbox of human iPSC-derived microglia for disease modelling and multicellular in vitro models for neurodegeneration drug discovery

Yates et al.

不良研究所

2025

Download poster
A robust platform of human iPSC-derived motor neurons for ALS disease modelling and neurodegeneration-focussed drug discovery Poster
A robust platform of human iPSC-derived motor neurons for ALS disease modelling and neurodegeneration-focussed drug discovery

Foulser et al.

不良研究所

2025

Download poster
In vitro model to study demyelinating disease using human OPC- and oligodendrocyte-like cells generated by deterministic cell programming Poster
In vitro model to study demyelinating disease using human OPC- and oligodendrocyte-like cells generated by deterministic cell programming

Veteleanu et al.

不良研究所

2025

Download poster
Optimisation of mRNA delivery to overcome transfection challenges in hiPSC-derived neurons and microglia Poster
Optimisation of mRNA delivery to overcome transfection challenges in hiPSC-derived neurons and microglia

Tatar Ozkan et al.

不良研究所

2025

Download poster
Cellular reprogramming to enable the precise and scalable manufacturing of human cells for therapeutic applications Talk
Cellular reprogramming to enable the precise and scalable manufacturing of human cells for therapeutic applications

Dr Alex Davenport | Senior Scientist | 不良研究所

Talk at ELRIG Cell & Gene Therapy

2021

Watch now
CRISPR and the Art of Perturbation Screening: Unbiased functional genomic screening meets the best human cellular models Talk
CRISPR and the Art of Perturbation Screening: Unbiased functional genomic screening meets the best human cellular models

Kam Dhaliwal | SVP Strategic Alliances | 不良研究所


Talk at ELRIG CRISPR in Drug Discovery

Watch now
Consistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery Talk
Consistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery

Kam Dhaliwal |  SVP Strategic Alliances | 不良研究所
Dr Thomas Moreau | Head of Research | 不良研究所


Talk at ELRIG Drug Discovery Digital

Watch now
Solving the R&D efficiency conundrum within Drug Discovery: Thoughts, Insights and Solutions Talk
Solving the R&D efficiency conundrum within Drug Discovery: Thoughts, Insights and Solutions

不良研究所 (chair) |  AstraZeneca | PhoreMost Ltd | Aelian Biotechnology GmbH | Charles River

 

Panel discussion at ELRIG Drug Discovery Digital

Watch now
Addressing current challenges of in vitro cell models Talk
Addressing current challenges of in vitro cell models

Kings College London & 不良研究所

Panel discussion at Oxford Global Discovery UK

Watch now
Precision Cellular Reprogramming for Scalable and Consistent Human Neurodegenerative Disease Models Talk
Precision Cellular Reprogramming for Scalable and Consistent Human Neurodegenerative Disease Models

Madeleine Garrett | Field Application Specialist | 不良研究所

Watch now
Industrialising Cellular Reprogramming: Leveraging opti-ox Technology to Manufacture Human Cells with Unprecedented Consistency Talk
Industrialising Cellular Reprogramming: Leveraging opti-ox Technology to Manufacture Human Cells with Unprecedented Consistency

Innovation showcase talk at ISSCR

Marius Wernig MD, PhD | Stanford 

Mark Kotter, MD, PhD | 不良研究所

Watch now
Ameliorating cellular stress in neurodegeneration Talk
Ameliorating cellular stress in neurodegeneration

Dr Emmanouil Metzakopian | Visiting researcher | University of Cambridge

 

Human Cell Forum 2025
Session 1 Track 1 | Modelling neurodegeneration in vitro with human  iPSC-derived cells

Watch now
In Vitro Approaches to Neurodegeneration: Characterisation of ioGlutamatergic Neurons as PD models Talk
In Vitro Approaches to Neurodegeneration: Characterisation of ioGlutamatergic Neurons as PD models

Dr Irantzu Perez Ruiz | Study Director | Scantox Neuro

 

Human Cell Forum 2025
Session 1 Track 1 | Modelling neurodegeneration in vitro with human iPSC-derived cells

Watch now
Characterising disease relevant signatures in iPSC-derived motor neurons to test the therapeutic potential of homeoprotein EN1 Talk
Characterising disease relevant signatures in iPSC-derived motor neurons to test the therapeutic potential of homeoprotein EN1

Dr Elizabeth Di Lullo | Associate Scientific Director | BrainEver

Human Cell Forum 2025
Session 1 Track 1 | Modelling neurodegeneration in vitro with human iPSC-derived cells

Watch now
Using ioSensory Neurons to model pain in osteoarthritis Talk
Using ioSensory Neurons to model pain in osteoarthritis

Dr Ryan Jones | Research Associate | Cardiff University


Human Cell Forum 2025
Session 1 Track 2 | From cells to systems: Building human iPSC-derived models of pain, neuromuscular junctions, and glial dynamics

Watch now
Astrocytic calcium imaging 鈥� from mouse to human systems Talk
Astrocytic calcium imaging 鈥� from mouse to human systems

Jeremy Krohn | PhD Candidate | DZNE / Charit茅 University of Medicine

 

Human Cell Forum 2025
Session 1 Track 2 | From cells to systems: Building human iPSC-derived models of pain, neuromuscular junctions, and glial dynamics

Watch now
Using human iPSC-derived ioSkeletal Myocytes and ioMotor Neurons to model complex neuromuscular systems in vitro Talk
Using human iPSC-derived ioSkeletal Myocytes and ioMotor Neurons to model complex neuromuscular systems in vitro

Dr Grace Cooper | Senior Scientist | 不良研究所

 

Human Cell Forum 2025
Session 1 Track 2 | From cells to systems: Building human iPSC-derived models of pain, neuromuscular junctions, and glial dynamics

Watch now
Unlocking success with ioCells: Overcoming challenges and maximising outcomes Talk
Unlocking success with ioCells: Overcoming challenges and maximising outcomes

Luke Foulser | Field Applications Scientist | 不良研究所

 

Human Cell Forum 2025
Session 2 | 不良研究所 insider: Tools, tips, and what鈥檚 coming next

Watch now
Comparing human iPSC-derived ioMicroglia to immortalised HMC3 cell line: A case study Talk
Comparing human iPSC-derived ioMicroglia to immortalised HMC3 cell line: A case study

Euan Yates | Scientist | 不良研究所

 

Human Cell Forum 2025
Session 2 | 不良研究所 insider: Tools, tips, and what鈥檚 coming next

Watch now
Development of human iPSC-derived hepatocytes for drug discovery, translational research and toxicity testing Talk
Development of human iPSC-derived hepatocytes for drug discovery, translational research and toxicity testing

Dr Gianmarco Mastrogiovanni | Principal Scientist - Cell Type Development | 不良研究所

 

Human Cell Forum 2025
Session 2 | 不良研究所 insider: Tools, tips, and what鈥檚 coming next

Watch now
CRISPR meets opti-ox鈩� - Harnessing CRISPR-Ready ioCells for drug discovery in neurodegenerative diseases Talk
CRISPR meets opti-ox鈩� - Harnessing CRISPR-Ready ioCells for drug discovery in neurodegenerative diseases

Sejla Salic-Hainzl | Vice President of R&D | 不良研究所 discovery

 

Human Cell Forum 2025
Session 2 | 不良研究所 insider: Tools, tips, and what鈥檚 coming next

Watch now
rAAV meets ioNeurons: Pioneering the future of translational neurotherapies Talk
rAAV meets ioNeurons: Pioneering the future of translational neurotherapies

Dr Martina Esposito Soccoio | Senior Research Associate | AviadoBio

 

Human Cell Forum 2025
Session 3 | Making complex human biology compatible with modern drug discovery workflows

Watch now
Toward clinical trial in a dish: harnessing iPSC models in drug discovery Talk
Toward clinical trial in a dish: harnessing iPSC models in drug discovery

Dr Sara Martin | Scientist | Axxam

 

Human Cell Forum 2025 
Session 3 | Making complex human biology compatible with modern drug discovery workflows

Watch now
Targeting Neurodegeneration: An AI-guided Visual Biology Approach to discover drug targets for neurodegenerative disease Talk
Targeting Neurodegeneration: An AI-guided Visual Biology Approach to discover drug targets for neurodegenerative disease

Dr Ben Bar-Sadeh | Senior Scientist | Anima Biotech

 

Human Cell Forum 2025 
Session 3 | Making complex human biology compatible with modern drug discovery workflows

Watch now
Partnering with Charles River to advance CNS drug discovery with ioGlutamatergic Neurons Video
Partnering with Charles River to advance CNS drug discovery with ioGlutamatergic Neurons

Dr Marijn Vlaming | Head of Biology, et al.

Charles River & 不良研究所

Watch
In Conversation with Charles River Video
In Conversation with Charles River

Dr Marijn Vlaming | Head of Biology
Charles River

Watch
Accelerating in vitro target and drug discovery using reprogrammed glutamatergic neurons Video
Accelerating in vitro target and drug discovery using reprogrammed glutamatergic neurons

Dr Shushant Jain | Group Leader In Vitro Biology | Charles River

Interview at SLAS

Watch
Introducing ioSkeletal Myocytes | Developing the next generation of human muscle cells Video
Introducing ioSkeletal Myocytes | Developing the next generation of human muscle cells

Dr Will Bernard | Director of Cell Type Development | 不良研究所

Watch
Introducing ioGlutamatergic Neurons HTT 50CAG/WT | A next-generation approach to study Huntington's disease Video
Introducing ioGlutamatergic Neurons HTT 50CAG/WT | A next-generation approach to study Huntington's disease

不良研究所

Watch
opti-ox by 不良研究所 Video
opti-ox by 不良研究所

V2

不良研究所

2023

Watch
SynBio + Pharma: Revolutionizing the Future of Medicine Main Stage at SynBioBeta 2023 Video
SynBio + Pharma: Revolutionizing the Future of Medicine Main Stage at SynBioBeta 2023
SynBioBeta 2023 Main stage
Watch
MaxWell Summit 2024 Poster Presentation with Luke Foulser ioMotor Neurons Video
MaxWell Summit 2024 Poster Presentation with Luke Foulser ioMotor Neurons

Luke Foulser | Scientist | 不良研究所

Watch
The developmental capacity of nuclei transplanted from keratinized skin cells of adult frogs Video
The developmental capacity of nuclei transplanted from keratinized skin cells of adult frogs

Dr Daniel Ortmann | Head of Discovery | 不良研究所

Read more
Induction of pluripotent stem cells from adult human fibroblasts by defined factors Video
Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Dr Anne-Claire Gu茅nantin | Senior Scientist | 不良研究所

Read more
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes Video
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

Dr Will Bernard | Senior Scientist | 不良研究所

Read more
Direct conversion of fibroblasts to functional neurons by defined factors Video
Direct conversion of fibroblasts to functional neurons by defined factors

Dr Tony Oosterveen | Senior Scientist | 不良研究所

Read more
Genetic content of adult somatic cells tested by nuclear transplantation from cultured cells Video
Genetic content of adult somatic cells tested by nuclear transplantation from cultured cells

Dr Kaiser Karim | Senior Scientist | 不良研究所

Read more
Stepwise reprogramming of B cells into macrophages Video
Stepwise reprogramming of B cells into macrophages

Dr Thomas Moreau | Head of Research | 不良研究所

Read more
Haematopoietic stem and progenitor cells from human pluripotent stem cellsfo Video
Haematopoietic stem and progenitor cells from human pluripotent stem cellsfo

Dr Thomas Moreau | Head of Research | 不良研究所

Read more
Advances in cellular reprogramming: from stem cells to printed tissues | 不良研究所 Webinar
Advances in cellular reprogramming: from stem cells to printed tissues | 不良研究所

Prof Hagan Bayley | University of Oxford
Dr Mark Kotter | Founder and CEO | 不良研究所

Watch now
Research in Motion with ioSkeletal Myocytes | 不良研究所 Webinar
Research in Motion with ioSkeletal Myocytes | 不良研究所

Dr Luke Flatt | Senior Scientist | Charles River Laboratories

Dr Will Bernard | Senior Scientist | 不良研究所




Watch now
Modelling neurodevelopment | Investigating the impact of maternal immune activation on neurodevelopment using human iPSC-derived cells | 不良研究所 Webinar
Modelling neurodevelopment | Investigating the impact of maternal immune activation on neurodevelopment using human iPSC-derived cells | 不良研究所

Dr Deepak Srivastava | King鈥檚 College London

Watch now
Modelling human neurodegenerative diseases in research & drug discovery | 不良研究所 Webinar
Modelling human neurodegenerative diseases in research & drug discovery | 不良研究所

Dr Mariangela Iovino | Group Leader | Charles River

Dr Tony Oosterveen | Senior Scientist | 不良研究所

Watch now
Improving Huntington鈥檚 disease drug discovery with new reproducible disease models | 不良研究所 Webinar
Improving Huntington鈥檚 disease drug discovery with new reproducible disease models | 不良研究所

Dr Emma V Jones | Senior Scientist | Medicines Discovery Catapult

Dr Tony Oosterveen | Senior Scientist | 不良研究所

Watch now
Alzheimer鈥檚 Disease Pathogenesis: Emerging Role of Microglia | 不良研究所 Webinar
Alzheimer鈥檚 Disease Pathogenesis: Emerging Role of Microglia | 不良研究所

Dr Matthias Pawlowski | Head, Dementia-Sensitive Hospital | University of M眉nster

Dr Malathi Raman | Senior Product Manager | 不良研究所

Watch now
Unlocking the Potential of RNA Therapies in Autism Spectrum Disorder How Definitive Human iPSC-derived Cells are Paving the Way | 不良研究所 Webinar
Unlocking the Potential of RNA Therapies in Autism Spectrum Disorder How Definitive Human iPSC-derived Cells are Paving the Way | 不良研究所

Rodney A. Bowling Jr., Ph.D. | Chief Scientific Officer |  Everlum Bio

Malathi Raman Ph.D. | Senior Product Manager | 不良研究所

Watch now
Rethinking Developmental Biology With Cellular Reprogramming | 不良研究所 Webinar
Rethinking Developmental Biology With Cellular Reprogramming | 不良研究所

Mark Kotter | CEO and founder | 不良研究所

Marius Wernig | Professor Departments of Pathology and Chemical and Systems Biology |  Stanford University

Watch now
Addressing the Reproducibility Crisis | Driving Genome-Wide Consistency in Cellular Reprogramming | 不良研究所 Webinar
Addressing the Reproducibility Crisis | Driving Genome-Wide Consistency in Cellular Reprogramming | 不良研究所

Dr Ania Wilczynska | Head of Computational Genomics | Non-Clinical | 不良研究所

Watch now
Mastering Cell Identity In A Dish: The Power Of Cellular Reprogramming | 不良研究所 Webinar
Mastering Cell Identity In A Dish: The Power Of Cellular Reprogramming | 不良研究所

Prof Roger Pedersen | Adjunct Professor and Senior Research Scientist at Stanford University 

Dr Thomas Moreau | Director of Cell Biology Research | 不良研究所

Watch now
Advancements in 3D modeling: Building mature, functional 3D skeletal muscle microtissues in vitro | 不良研究所 Webinar
Advancements in 3D modeling: Building mature, functional 3D skeletal muscle microtissues in vitro | 不良研究所

Dr Marieke Aarts | Principal Scientist | Bi/ond

Amanda Turner | Senior Product Manager | 不良研究所

Watch now
Running Large-Scale CRISPR Screens in Human Neurons | 不良研究所 Webinar
Running Large-Scale CRISPR Screens in Human Neurons | 不良研究所

Emmanouil Metzakopian | Vice President, Research and Development | 不良研究所

Javier Conde-Vancells | Director Product Management | 不良研究所

Watch now
Empowering motor neuron disease research and drug discovery with a new class of functional, reproducible hiPSC-derived motor neurons | 不良研究所 Webinar
Empowering motor neuron disease research and drug discovery with a new class of functional, reproducible hiPSC-derived motor neurons | 不良研究所

Tom Brown | Senior Product Manager | 不良研究所

Marcos Herrera Vaquero, PhD | Senior Scientist | 不良研究所
Watch now
Uncovering the Glioma Microenvironment With In Vitro Neuronal Models | 不良研究所 Webinar
Uncovering the Glioma Microenvironment With In Vitro Neuronal Models | 不良研究所

Dr Brian Gill, MD | Assistant Professor of Neurological Surgery| Columbia University Irving Medical Center

Dr Tony Oosterveen | Principal Scientist and CNS Lead, Neurobiology | 不良研究所

 

Watch now
Exploring the critical roles of astrocytes in health and disease | 不良研究所 Webinar
Exploring the critical roles of astrocytes in health and disease | 不良研究所
Jeremy Krohn | PhD candidate | German Center for Neurodegenerative Diseases (DZNE) Charit茅 Medical Neuroscience Graduate Program

Tom Brown | Senior Product Manager | 不良研究所
Watch now
Powering a new generation of physiologically relevant CRISPR screens | 不良研究所 Webinar
Powering a new generation of physiologically relevant CRISPR screens | 不良研究所

Professor Luke Gilbert | Associate Professor | University of California San Francisco

Sejla Salic-Hainzl | Vice President of Research and Development | 不良研究所

Watch now
Human iPSC-Based Models of Glial Cells for Studying Neurodegenerative Disease | 不良研究所 Webinar
Human iPSC-Based Models of Glial Cells for Studying Neurodegenerative Disease | 不良研究所
Valentina Fossati, PhD | Senior Research Investigator | The New York Stem Cell Foundation

In锚s Ferreira | Senior Product Manager | 不良研究所
Watch now
Principles, pitfalls, and progress in modelling human liver toxicity and pharmacology in vitro | 不良研究所 Webinar
Principles, pitfalls, and progress in modelling human liver toxicity and pharmacology in vitro | 不良研究所

Stephen Ferguson, PhD | Investigator, Mechanistic Toxicology | Division of Translational Toxicology (DTT) | National Institute of Environmental Health Sciences

 

Tom Brown | Senior Product Manager | 不良研究所

Watch now
Sex differences in neurological research | 不良研究所 Webinar
Sex differences in neurological research | 不良研究所

Antonella Santuccione Chadha, MD | Founder and CEO | Women鈥檚 Brain Foundation

Melanie Einsiedler, PhD | Scientific Contributor | Women鈥檚 Brain Foundation


Rebecca Northeast, PhD | Senior Product Manager | 不良研究所

Watch now
Progress in applying human iPSC-derived cells to drug discovery | 不良研究所 Webinar
Progress in applying human iPSC-derived cells to drug discovery | 不良研究所

Sebastian Fiedler, PhD | Applications Marketing Manager | 不良研究所

Malika Bsibsi, PhD | Research Leader Neuroscience | Charles River Laboratories


Austin Passaro, PhD | Global Product Manager MEA | Axion Biosystems


Cicely Schramm, PhD | Head of Biology Imaging | Sartorius

Watch now
Harnessing AI-guided visual biology to discover drug targets for neurodegenerative disease | 不良研究所 Webinar
Harnessing AI-guided visual biology to discover drug targets for neurodegenerative disease | 不良研究所

Ben Bar-Sadeh, PhD | Senior Scientist | Anima Biotech

Tom Brown | Senior Product Manager | 不良研究所

Watch now
Tackling the reproducibility crisis with standardised human cells | 不良研究所 Webinar
Tackling the reproducibility crisis with standardised human cells | 不良研究所

Marius Wernig, Professor | Departments of Pathology and Chemical, and Systems Biology and Co-Director of the Institute for Stem Cell Biology and Regenerative Medicine | Stanford University

Samantha Morris, PhD | Principle Investigator | Brigham and Women鈥檚 Hospital and Harvard Medical School, Department of Systems Biology


Thomas Moreau, PhD | Vice President of Cell Programming Research | 不良研究所

 

Watch now
MEA Workshop - tips and tricks for iPSC-derived neurons | 不良研究所 Webinar
MEA Workshop - tips and tricks for iPSC-derived neurons | 不良研究所

Luke Foulser, MSc | Field Applications Scientist | 不良研究所


Austin Passaro, PhD | Global Product Manager MEA | Axion Biosystems

Watch now
Cell counting workshop | Top tips for human iPSC-derived cells | 不良研究所 Webinar
Cell counting workshop | Top tips for human iPSC-derived cells | 不良研究所

Jack Gowen, MSc | Scientist, QC and GMP, Analytical Development | 不良研究所


Charlotte Durham, BSc | Operational Quality Manager | 不良研究所

Watch now
Exploring the application of deterministically programmed hiPSCs to advance early-stage drug discovery | 不良研究所 Webinar
Exploring the application of deterministically programmed hiPSCs to advance early-stage drug discovery | 不良研究所

Thomas Moreau, PhD | VP Cell Programming Research | 不良研究所


Ann Byrne, MSc | Regional Sales Manager, APAC | 不良研究所


Gianmarco Mastrogiovanni, PhD | Principle Scientist - Cell Type Development | 不良研究所

 

 

Watch now
Immunocytochemistry workshop Top tips for human iPSC-derived cells | 不良研究所 Webinar
Immunocytochemistry workshop Top tips for human iPSC-derived cells | 不良研究所

Fuad Mosis, PhD | Technical Support Specialist | 不良研究所

Watch now
Transfection workshop Top tips for human iPSC-derived cells | 不良研究所 Webinar
Transfection workshop Top tips for human iPSC-derived cells | 不良研究所

Sarah Hussain | Scientist | 不良研究所


Tulin Tatar Ozkan, PhD | Senior Scientist II | 不良研究所

Watch now
RNA-sequencing workshop Top tips for human iPSC-derived cells | 不良研究所 Webinar
RNA-sequencing workshop Top tips for human iPSC-derived cells | 不良研究所
Val Yianni, PhD | Senior Scientist, Computational Biology | 不良研究所
Watch now

Related pages

Our platform Discover the cell coding platform behind our cells
Resources Explore our latest scientific insights, webinars, blogs and videos
Contact us Talk to us to learn more about our team and products